A huge thank you to the @BCRT for organising such fantastic conferences, and to @Sarcoma_UK for funding my research. (3/3) #SarcomaAwarenessMonth #EwingSarcoma #CancerResearch #Immunotherapy #BoneCancer #SarcomaResearch

It was an privilege representing @LIMRLeeds and @UniversityLeeds to present a poster on some of our work exploring novel immunotherapies for Ewing sarcoma, and I was honoured to be awarded the Poster Prize! 🎉 (2/3)

Just back from an inspiring few days in London at the @euroewing & Advances in Ewing Sarcoma Research meetings — two fantastic events bringing together researchers, clinicians, and advocates working to improve outcomes for people affected by Ewing sarcoma. (1/3)

Delighted for the opportunity to represent @LIMRLeeds and present some of our research at #EuSARC24 exploring novel immunotherapies for the treatment of #Ewingsarcoma Thanks @BCRT for making attendance possible with their travel grant! @eu_sarc @Sarcoma_UK

Brilliant work by @RichardBaugh3, funded by one of our PhD studentships, offering a new strategy for targeting treatment-resistant cancer stem cells in glioblastoma.

Delighted to share our new manuscript published this week in @JITC showcasing a novel oncolytic herpes simplex virus armed to express a Bi-specific T cell Engager which targets NKG2D ligands in glioblastoma. @Oncolytics_oxon @OxfordOncology @BRUKresearch

New #JITC article: Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells https://t.co/VIHaapI1Ll @RichardBaugh3 @wktpeter

Dr Richard Baugh @LeedsMedHealth @LTHTResearch is up next, presenting research evaluating the effect of pro-inflammatory cytokines on oncolysis mediated by the oncolytic virus coxsackievirus A-21 in patient-derived Ewing sarcoma cell cultures #AESR

Fiona and team at @UniversityLeeds are working on 'cancer-bursting' viruses, which can invade Ewing sarcoma cells directly or make our immune systems attack and kill the cancer. #BoneCancerAwarenessWeek https://t.co/RdY6EP2FOy

Thank you from the bottom of my heart to everyone that has helped make my time here such an enjoyable experience over the years. Now, a new adventure awaits at the University of Leeds! @Oncolytics_oxon @OxfordOncology

Today marks my last day at the University of Oxford after almost 10 years. I have had the honour of meeting and working alongside some amazing and incredibly talented people, who I will miss dearly.

Thank you all for coming to the @OxfordOncology @The_OIRO post-doc #Christmas social! Happy Christmas & New Year's! @onco_hannah @_anjaliarora @TessStanly @RichardBaugh3 @nuriavl1993 @SusannaPhyu @halaestephan @ScottCo85123133

Some highlights from last week when members of the Seymour Lab presented their brilliant research at the 14th International Oncolytic Virus Conference 2022 in Karuizawa, Japan #IOVC22

@RichardBaugh3 from Len Seymour lab, giving his talk on bispecific #Tcell engagers- BiTE for #virotherapy of glioblastoma at the postdoc away day @OxfordOncology

🎉Enormous congratulations to Dr Richard Baugh, who successfully defended his DPhil thesis last week 🎉 We're proud to have supported him through his DPhil; read about his research, focused on the immunotherapy of glioblastoma here 👉 https://t.co/AsqqRo5R0T

Congratulations to Dr @RichardBaugh3 who successfully defended his DPhil thesis last week! Many thanks to the wonderful examiners @eileen_parkes and @LamfersMartine @BRUKresearch

Submitted my PhD thesis on Friday! Thank you to everyone who helped me along the way! @BRUKresearch @Oncolytics_oxon @OxfordOncology

Read the meeting abstracts from the AACR Virtual Special Conference: Tumor Immunology and Immunotherapy. They are now published as a supplement to the January issue of Cancer Immunology Research. https://t.co/LBybbJmHE0 #AACRtii21

Christmas Countdown Day 9 - another impactful study from Oxford cancer research @OxfordOncology @Oncolytics_oxon publish their work investigating the use of reprogramming herpes virus-1 to help destroy cancer cells 👉 https://t.co/qWwNQHpAcU

An incredible few days in Edinburgh for the #BSI21 Lots of fascinating science! Thankfully the journey home was a little easier. Roll on BSI22 in Liverpool! @bsicongress @Oncolytics_oxon